Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 12, 2000, Pages 2657-2662

  Rauramaa, Rainer ^a,b   Väisänen, Sari B ^a,b   Luong, Le Anh ^c   Schmidt Trücksäss, Arno ^d   Penttilä, Ilkka M ^a,b   Bouchard, Claude ^e   Töyry, Jari ^a   Humphries, Steve E ^c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Rayne Institute ^*  (United Kingdom)

^d UNIVERSITY OF FREIBURG   (Germany)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

B mode ultrasonography; Carotid atherosclerosis; DNA polymorphism; Interleukin 6; Population sample; Stromelysin 1

Indexed keywords

INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STROMELYSIN;

ADULT; ALLELISM; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAROTID ARTERY BIFURCATION; CAROTID ARTERY DISEASE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 0033669130     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.12.2657     Document Type: Article

References (44)

1. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
2. Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis
3. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
4. Protein kinase C-independent expression of stromelysin by platelet-derived growth factor, ras oncogene, and phosphatidylcholinehydrolyzing phospholipase C
5. Preliminary report: Genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis
6. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression
7. The 5A/6A polymorphism in the promoter of the stromelysin-1 (matrix metalloproteinase-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study: Lopid Coronary Angiography Trial
8. Efficacy of pravastatin treatment in coronary atherosclerosis is modulated by natural variation in the stromelysin-1 promoter
9. Interleukin-6 and the acute phase response
10. The insulin resistance syndrome and endothelial dysfunction as common consequences of cytokines originating from adipose tissue: A new paradigm for insulin resistance and cardiovascular risk
11. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
12. The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element
13. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain
14. Serum glycoproteins and severity of coronary atherosclerosis
15. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
16. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: Results at autopsy
17. Elevation of C-reactive protein in active coronary artery disease
18. Elevated levels of interleukin-6 in unstable angina
19. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury
20. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
21. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene: Their effect on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
22. Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2): Up-regulation by interleukin-6 and transforming growth factor beta 1
23. TIMP-1 protein expression is stimulated by IL-1 beta and IL-6 in primary rat hepatocytes
24. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men
25. Inverse relationship between cardiorespiratory fitness and carotid atherosclerosis
26. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging
27. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: The Carotid Atherosclerosis Italian Ultrasound Study
28. Snakes: Active contour models
29. Physical activity and health-related fitness in middle-aged men
30. Hemodynamics and atherosclerosis: Insights and perspectives gained from studies of human arteries
31. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: A role for CD40 signaling in plaque rupture?
32. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor
33. Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cells
34. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
35. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: Inhibition by 17β-estradiol
36. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events (CARE) Investigators
37. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
38. Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells
39. Gene-environment interaction in the determination of levels of plasma fibrinogen
40. Variation in the gene for interleukin-6 (IL-6) and inflammatory markers in healthy subjects
41. Decline of coronary heart disease mortality in Finland during 1983 to 1992: Roles of incidence recurrence and case-fatality: The FIN-MONICA MI Register Study